Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""DISEASES"" wg kryterium: Temat


Tytuł:
Akkermansia muciniphila improves chronic colitis-induced enteric neuroinflammation in mice.
Autorzy:
Yilmaz O; Department of Physiology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Okullu SO; Department of Microbiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Catakci M; Department of Physiology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Elmas MA; Department of Histology and Embryology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Pinheiro Y; Research Unit of Comparative Microbiome Analysis, Helmholtz Zentrum Muenchen, Munich, Germany.
Arbak S; Department of Histology and Embryology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Demir E; Department of Surgery, School of Medicine Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Schaefer KH; Research and Transfer Working Group Enteric Nervous System (AGENS), University of Applied Sciences Kaiserslautern, Zweibrücken, Germany.
Kolgazi M; Department of Physiology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.; Department of Physiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Pokaż więcej
Źródło:
Neurogastroenterology and motility [Neurogastroenterol Motil] 2024 Mar; Vol. 36 (3), pp. e14745. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis*/chemically induced
Colitis*/therapy
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Inflammatory Bowel Diseases*/microbiology
Mice ; Animals ; Neuroinflammatory Diseases ; Base Composition ; Sequence Analysis, DNA ; RNA, Ribosomal, 16S ; Phylogeny ; Verrucomicrobia/genetics ; Inflammation ; Chronic Disease ; Akkermansia
SCR Organism:
Akkermansia muciniphila
Czasopismo naukowe
Tytuł:
Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).
Autorzy:
Nanetti L; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy.
Kearney M; Patient Advocate at the European Reference Network Representing Individuals With Ataxia, and Neurology Research Fellow at the National Ataxia Centre, Tallaght University, Dublin, Ireland.
Boesch S; Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria.
Stovickova L; Centre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
Ortigoza-Escobar JD; Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Macaya A; Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain.
Gomez-Andres D; Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain.
Roze E; Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France.
Molnar MJ; Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.
Wolf NI; Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma's Children's Hospital, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands.
Darling A; Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
Vasco G; Research Unit of Neurorehabilitation, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Bertini E; Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Indelicato E; Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria.
Neubauer D; UMCL, Children's Hospital Ljubljana and University of Ljubljana, Ljubljana, Slovenia.
Haack TB; Institute of Medical Genetics and Applied Genomics University of Tübingen, Tübingen, Germany.
Sagi JC; Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.; Department of Paediatrics, Semmelweis University, Dept. of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
Danti FR; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Sival D; Department of Paediatric Neurology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Zanni G; Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
Kolk A; Tartu University Hospital Children's Clinic, Department of Pediatrics and Neurology, Tartu, Estonia.
Boespflug-Tanguy O; APHP, Université Paris Cité, INSERM UMR1141, Hôpital Robert Debré, Service de Neuropédiatrie, Centre de Reference LEUKOFRANCE, Paris, France.
Schols L; Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany.
van de Warrenburg B; Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Vidailhet M; Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France.
Willemsen MA; Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Buizer AI; Department of Rehabilitation Medicine, Emma Children's Hospital, Amsterdam, Vrije Universiteit, Amsterdam, Amsterdam Movement Science, Rehabilitation and Development, Amsterdam, The Netherlands.
Orzes E; Osservatorio Malattie Rare - Rarelab S.R.L., Rome, Italy.
Ripp S; Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
Reinhard C; Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.
Moroni I; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Mariotti C; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy. .
Pokaż więcej
Corporate Authors:
ERN-RND Working Group for Management of Transition
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Mar; Vol. 45 (3), pp. 1007-1016. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Delivery of Health Care*
Nervous System Diseases*/diagnosis
Nervous System Diseases*/therapy
Adult ; Adolescent ; Humans ; Child ; Surveys and Questionnaires ; Europe ; Rare Diseases/diagnosis ; Rare Diseases/therapy
Czasopismo naukowe
Tytuł:
The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on ataxias, dystonia and PKU. A scoping review.
Autorzy:
Cannizzo S; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Quoidbach V; European Brain Council, Brussels, Belgium.
Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
Oertel W; Philipps-Universitat Marburg, Marburg, Germany.
Pastores G; National Centre for inherited Metabolic Disorders, Mater Misericordiae University Hospital, Dublin, Ireland.
Relja M; University of Zagreb Medical School, Zagreb, Croatia.
Turchetti G; Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy. .; Fulbright Scholar, Institute of Management, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà, 33, 56127, Pisa, Italy. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 21; Vol. 19 (1), pp. 81. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
COVID-19*/epidemiology
Dystonia*
Phenylketonurias*
Brain Diseases*
Humans ; Pandemics ; Rare Diseases/epidemiology ; Rare Diseases/therapy ; Brain ; Ataxia ; Continuity of Patient Care
Czasopismo naukowe
Tytuł:
Long-term follow-up of torpedo maculopathy: a case series and mini-review.
Autorzy:
Trevino RC; School of Optometry, Indiana University, 800 Atwater Ave Bloomington, Bloomington, IN, 47405, USA. .
Ridder WH 3rd; Southern California College of Optometry, Marshall B. Ketchum University, Fullerton, CA, USA.
Laul A; College of Optometry, State University of New York, New York, NY, USA.
Hill J; College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Pokaż więcej
Źródło:
BMC ophthalmology [BMC Ophthalmol] 2024 Jan 03; Vol. 24 (1), pp. 5. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Retinal Diseases*/diagnosis
Retinal Diseases*/genetics
Retinal Diseases*/pathology
Macular Degeneration*/pathology
Humans ; Follow-Up Studies ; Retinal Pigment Epithelium/pathology ; Fluorescein Angiography/methods ; Visual Acuity ; Tomography, Optical Coherence/methods ; Rare Diseases/pathology
Czasopismo naukowe
Tytuł:
EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders.
Autorzy:
Atalaia A; Inserm Center of Research in Myology, Neuro-Myology Service G.H. Pitié-Salpêtrière, Sorbonne Université, Paris, France. .
Wandrei D; Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lalout N; Medical BioSciences Department, Radboud University Medical Center, Nijmegen, Netherlands.; Duchenne Parent Project, Veenendaal, The Netherlands.
Thompson R; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.
Tassoni A; Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
't Hoen PAC; Medical BioSciences Department, Radboud University Medical Center, Nijmegen, Netherlands.
Athanasiou D; World Duchenne Organisation, Veenendaal, The Netherlands.
Baker SA; World Duchenne Organisation, Veenendaal, The Netherlands.
Sakellariou P; Duchenne Data Foundation, Bergen Op Zoom, The Netherlands.
Paliouras G; Duchenne Data Foundation, Bergen Op Zoom, The Netherlands.
D'Angelo C; European Reference Network for Rare Neuromuscular Diseases EURO-NMD, Institute of Myology, University Hospital Pitie-Salpetriere-APHP, Paris, France.
Horvath R; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Mancuso M; Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
van der Beek N; Department of Neurology/Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Kornblum C; Department of Neurology, Neuromuscular Diseases Section, University Hospital Bonn, Bonn, Germany.
Kirschner J; Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Pareyson D; Unit of Rare Neurological Diseases. Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Bassez G; Neuromuscular Diseases Reference Center, Pitié-Salpêtrière University Hospital, APHP Paris, Paris, France.
Blacas L; Association Institute of Myology, Hôpital Pitié-Salpêtrière, Paris, France.
Jacoupy M; Association Institute of Myology, Hôpital Pitié-Salpêtrière, Paris, France.
Eng C; Association Française Contre Les Myopathies, AFM-Téléthon, Evry, France.
Lamy F; Association Française Contre Les Myopathies, AFM-Téléthon, Evry, France.
Plançon JP; European Patient Organisation for Dysimmune and Inflammatory Neuropathies, Paris, France.
Haberlova J; Neuromuscular Center, University Hospital Motol, Prague, Czech Republic.
Brusse E; Department of Neurology/Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Hoeijmakers JGJ; Department of Neurology, Maastricht University Medical Center+, and MHeNS, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
de Visser M; Department of Neurology, Amsterdam University Medical Center, Location Academic Medical Center, Amsterdam, The Netherlands.
Claeys KG; Department of Neurology, University Hospitals Leuven, and Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, KU Leuven, and Leuven Brain Institute (LBI), Louvain, Belgium.
Paradas C; Hospital Universitario Virgen del Rocío/IBiS, Avda Manuel Siurot S/N, 41013, Seville, Andalucía, Spain.
Toscano A; Department of Clinical and Experimental Medicine, AOU G. Martino Di Messina, University of Messina, Messina, Italy.
Silani V; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Gyenge M; Neuromuscular Diseases Reference Center, Pitié-Salpêtrière University Hospital, APHP Paris, Paris, France.
Reviers E; ALS Liga Belgium, Louvain, Belgium.
Hamroun D; CHRU de Montpellier, Direction de la Recherche et de L'Innovation, Hôpital La Colombière, Montpellier, France.
Vroom E; World Duchenne Organisation, Veenendaal, The Netherlands.
Wilkinson MD; Departamento de Biotecnología-Biología Vegetal, Escuela Técnica Superior de Ingeniería Agronómica, Alimentaria y de Biosistemas, Centro de Biotecnología y Genómica de Plantas UPM-INIA, Universidad Politécnica de Madrid (UPM), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA/CSIC), 28223, Madrid, ES, Spain.
Lochmuller H; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.; Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Evangelista T; Neuromuscular Pathology Functional Unit; Neuropathology Service, Institute of Myology, University Hospital Pitié-Salpêtrière-APHP, Paris, France.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 14; Vol. 19 (1), pp. 66. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neuromuscular Diseases*/genetics
Humans ; Registries ; Rare Diseases
Czasopismo naukowe
Tytuł:
Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseases.
Autorzy:
Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. .; Centre for Rare Diseases, University Hospital Tübingen, Tübingen, Germany. .
Reinhard C; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.; Centre for Rare Diseases, University Hospital Tübingen, Tübingen, Germany.
Bäumer T; Institute of Systems Motor Science, University of Lübeck, Lübeck, Germany.; Center for Rare Diseases, University of Lübeck and University Hospital Medical Center, Schleswig-Holstein, Germany.
Baumgärtner A; Institute of Health Sciences, University of Lübeck, Lübeck, Germany.
Brockmann K; Interdisciplinary Pediatric Center for Children With Developmental Disabilities and Severe Chronic Disorders, Department of Pediatrics and Adolescent Medicine, University Medical Center, Göttingen, Germany.
Brüggemann N; Center for Rare Diseases, University of Lübeck and University Hospital Medical Center, Schleswig-Holstein, Germany.; Department of Neurology, University Hospital Medical Center Schleswig-Holstein, Schleswig-Holstein, Germany.; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Bültmann E; Institute of Diagnostic Und Interventional Neuroradiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Erdmann J; Institute for Cardiogenetics, DZHK (German Research Centre for Cardiovascular Research), Partner Site Hamburg/Lübeck/Kiel, and University Heart Center Lübeck, University of Lübeck, Lübeck, Germany.
Heise K; Department of Health Sciences and Research, Medical University of South Carolina, Charleston, USA.; Department of Movement Sciences, Movement Control and Neural Plasticity Research Group, KU Leuven, Louvain, Belgium.
Höglinger G; Department of Neurology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.; Department of Neurology, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Straße 17, 81377, Munich, Germany.
Hüning I; Institute of Human Genetics, University of Lübeck, Lübeck, Germany.
Kaiser FJ; Essen Center for Rare Diseases (Essener Zentrum Für Seltene Erkrankungen, EZSE), University Hospital Essen, Essen, Germany.
Klein C; Institute of Neurogenetics, University of Lübeck and University Hospital Medical Center , Schleswig-Holstein, Germany.
Klopstock T; Friedrich Baur Institute at the Department of Neurology, University Hospital, LMU , Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Krägeloh-Mann I; Department of Pediatric and Developmental Neurology, Social Pediatrics, University of Tübingen, Tübingen, Germany.
Kraemer M; Department of Neurology, Alfried Krupp Hospital Essen, Essen, Germany.; Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Luedtke K; Department of Physiotherapy, Institute of Health Sciences, University of Lübeck, Lübeck, Germany.
Mücke M; Institute for Digitalization and General Medicine, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany.; Center for Rare Diseases Aachen (ZSEA), RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany.; Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany.
Musacchio T; Department of Neurology, University Hospital of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany.; Center for Rare Diseases, University Hospital of Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.
Nadke A; Deutsche Heredo-Ataxie-Gesellschaft E.V., Stuttgart, Germany.
Osmanovic A; Essen Center for Rare Diseases (Essener Zentrum Für Seltene Erkrankungen, EZSE), University Hospital Essen, Essen, Germany.
Ritter G; Klinikum Ameos, 23774 Heiligenhafen Friedrich Ebertstrrasse 100 Huntington Zentrum Nord, Heiligenhafen, Germany.
Röse K; Institute of Health Sciences, University of Lübeck, Lübeck, Germany.
Schippers C; Center for Rare Diseases Aachen (ZSEA), University Hospital Aachen, Aachen, Germany.
Schöls L; Centre for Rare Diseases, University Hospital Tübingen, Tübingen, Germany.; Department of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Schüle R; Division of Neurodegenerative Diseases, Department of Neurology, Heidelberg University Hospital and Faculty of Medicine, Heidelberg, Germany.; Center for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Schulz JB; Department of Neurology and Center for Rare Diseases, University Hospital, RWTH Aachen University, Aachen, Germany.
Sproß J; Deutsche Gesellschaft Für Muskelkranke e.V. Im Moos 4, 79112, Freiburg, Germany.
Stasch E; Deutsche PSP-Gesellschaft e.V. Weingartenstr. 28a, 61231, Bad Nauheim, Germany.
Wunderlich G; Faculty of Medicine and University Hospital, Department of Neurology, University of Cologne, Cologne, Germany.
Münchau A; Institute of Systems Motor Science, University of Lübeck, Lübeck, Germany.; Center for Rare Diseases, University of Lübeck and University Hospital Medical Center, Schleswig-Holstein, Germany.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 13; Vol. 19 (1), pp. 62. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Nervous System Diseases*/diagnosis
Nervous System Diseases*/therapy
Neurology*
Child ; Humans ; Rare Diseases/therapy ; Delivery of Health Care ; Consensus
Czasopismo naukowe
Tytuł:
The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review.
Autorzy:
Tirelli C; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Rondinone O; Medical Genetics Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Italia M; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Mira S; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Belmonte LA; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
De Grassi M; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Guido G; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Maggioni S; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Mondoni M; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Miozzo MR; Medical Genetics Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Centanni S; Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 11; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Niemann-Pick Disease, Type A*/genetics
Niemann-Pick Disease, Type A*/metabolism
Niemann-Pick Disease, Type A*/therapy
Niemann-Pick Disease, Type B*/genetics
Niemann-Pick Disease, Type B*/therapy
Niemann-Pick Diseases*/genetics
Niemann-Pick Diseases*/therapy
Lung Diseases*/genetics
Lung Diseases*/therapy
Humans ; Mutation ; Rare Diseases ; Lung/metabolism
Czasopismo naukowe
Tytuł:
The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network.
Autorzy:
Rahabi H; Service d'endocrinologie, hôpital de la Conception, centre de référence des maladies rares de l'hypophyse HYPO, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
Givony M; Service d'endocrinologie, filière santé maladies rares endocriniennes FIRENDO, Assistance Publique-Hôpitaux de Paris, Groupe hospitalo-universitaire AP-HP Centre, Hôpital Cochin, 75014 Paris, France.
Demaret B; Association GRANDIR, 92600 Asnières-sur-Seine, France.
Albarel F; Service d'endocrinologie, hôpital de la Conception, centre de référence des maladies rares de l'hypophyse HYPO, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
Aubron MR; Association Craniopharyngiome-solidarité, 65000 Tarbes, France.
Bartès B; Association Vivre sans Thyroïde, 31490 Léguevin, France.
Bernard L; MAIA: Association pour aider toutes personnes confrontées à l'infertilité, 61140 Bagnoles de l'Orne, France.
Abdoul H; URC Paris Descartes Necker/Cochin, hôpital Tarnier, 75006 Paris, France.
Bouazza N; URC Paris Descartes Necker/Cochin, hôpital Tarnier, 75006 Paris, France.
Brun P; Association ASSYMCAL: Syndrome de Mc Cune Albright dysplasie fibreuse de l'os, 85000 La Roche sur Yon, France.
Drui D; Service d'endocrinologie, l'institut du thorax, centre hospitalier universitaire de Nantes, Boulevard Jacques Monod, 44093 Nantes Cedex, France.
Dujardin V; Valentin APAC: Association de Porteurs d'Anomalies Chromosomiques, 95610 Eragny-sur-Oise, France.
Lançon C; Acromégales, Pas Seulement..., association nationale de l'acromégalie reconnue d'intérêt général, 59234 Villers-au Tertre, France.
Malivoir S; Assistance Publique-Hôpitaux de Paris, hôpital Armand Trousseau, 75571 Paris, France.
Netchine I; Assistance Publique-Hôpitaux de Paris, hôpital Armand Trousseau, 75571 Paris, France.
Perrotin B; AFIF SSR/PAG: Association Française des Familles touchées par le Syndrome de Silver Russell (SSR) et des personnes nées Petites pour l'Age Gestationnel (PAG) et leurs amis, 30390 Domazan, France.
Picard V; Association du Syndrome de Wolfram, 56390 Grand-Champ, France.
Reynaud R; Service de pédiatrie multidisciplinaire, hôpital de la Timone Enfants, centre de référence des maladies rares de l'hypophyse HYPO, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France; Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (Inserm), U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), Marseille, France.
Ribeiro M; Plateforme PRIOR, Centre Hospitalier Universitaire d'Angers, 49000 Angers, France.
Tardy Guidollet V; Hospices Civils de Lyon (HCL), laboratoire de biologie médical multisites, centre de référence DEV-GEN, 69677 Bron, France.
Victor A; Association syndrome de Rokitansky- MRKH, 75013 Paris, France.
Bertherat J; Service d'endocrinologie, filière santé maladies rares endocriniennes FIRENDO, Assistance Publique-Hôpitaux de Paris, Groupe hospitalo-universitaire AP-HP Centre, Hôpital Cochin, 75014 Paris, France; Service d'endocrinologie, centre de référence maladies rares de la Surrénale, 75014, Paris France. Université Paris Cité, Inserm U1016, CNRS UMR 8104, Institut Cochin, Génomique et Signalisation des Tumeurs Endocrines, Assistance Publique-Hôpitaux de Paris, Groupe hospitalo-universitaire AP-HP Centre, Hôpital Cochin, Paris, France.
Colin C; Association Surrénales, 35200 Rennes, France.
Brue T; Service d'endocrinologie, hôpital de la Conception, centre de référence des maladies rares de l'hypophyse HYPO, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France; Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (Inserm), U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), Marseille, France. Electronic address: .
Pokaż więcej
Źródło:
Annales d'endocrinologie [Ann Endocrinol (Paris)] 2024 Feb; Vol. 85 (1), pp. 27-35. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Endocrine System Diseases*/diagnosis
Endocrine System Diseases*/therapy
Cushing Syndrome*
Adrenal Hyperplasia, Congenital*
Adult ; Child ; Humans ; Rare Diseases/diagnosis ; Rare Diseases/therapy ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System.
Autorzy:
DePaula-Silva AB; Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT 84112, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 13; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Theilovirus*
Neurodegenerative Diseases*
Multiple Sclerosis*
Epilepsy*
Virus Diseases*
Animals ; Mice ; Microglia ; Neuroinflammatory Diseases ; Central Nervous System ; Brain ; Macrophages ; Seizures
Czasopismo naukowe
Tytuł:
Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders.
Autorzy:
Nezhad Salari AM; Student Research Committee, Bam University of Medical Sciences, Bam, Iran.
Rasoulizadeh Z; Student Research Committee, Bam University of Medical Sciences, Bam, Iran.
Shabgah AG; School of Medicine, Bam University of Medical Sciences, Bam, Iran.
Vakili-Ghartavol R; Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Sargazi G; Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Gholizadeh Navashenaq J; Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Pokaż więcej
Źródło:
Cell biochemistry and function [Cell Biochem Funct] 2024 Mar; Vol. 42 (2), pp. e3964.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neuroprotective Agents*/pharmacology
Neuroprotective Agents*/therapeutic use
Nervous System Diseases*/drug therapy
Humans ; Neuroprotection ; Neuroinflammatory Diseases ; Kaempferols/pharmacology ; Kaempferols/therapeutic use ; Phosphatidylinositol 3-Kinases
Czasopismo naukowe
Tytuł:
Cluster analysis and visualisation of electronic health records data to identify undiagnosed patients with rare genetic diseases.
Autorzy:
Moynihan D; Curtin University, Perth, Australia.
Monaco S; Health Catalyst, Utah, USA.
Ting TW; Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.
Narasimhalu K; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; Department of Neurology, National Neuroscience Institute (Singapore General Hospital), Singapore, Singapore.
Hsieh J; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; Department of Internal Medicine, Singapore General Hospital, Singapore, Singapore.
Kam S; Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.
Lim JY; Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.
Lim WK; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore.; Cancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; Laboratory of Genome Variation Analytics, Genome Institute of Singapore, Singapore, Singapore.
Davila S; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore.
Bylstra Y; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore.
Balakrishnan ID; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore.; National Heart Centre Singapore, Singapore, Singapore.
Heng M; SingHealth Office of Insights and Analytics, Singapore, Singapore.
Chia E; SingHealth Office of Insights and Analytics, Singapore, Singapore.
Yeo KK; National Heart Centre Singapore, Singapore, Singapore.
Goh BK; Data Analytics Office, KK Women's and Children's Hospital, Singapore, Singapore.
Gupta R; Curtin University, Perth, Australia.
Tan T; Curtin University, Perth, Australia.
Baynam G; Rare Care Centre, Perth Children's Hospital, Perth, WA, Australia.; Western Australian Register of Developmental Anomalies, Perth, WA, Australia.
Jamuar SS; Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. .; SingHealth Duke-NUS Genomic Medicine Centre, Singapore, Singapore. .; SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5056. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Fabry Disease*
Hyperlipoproteinemia Type II*/genetics
Undiagnosed Diseases*
Humans ; Rare Diseases/diagnosis ; Rare Diseases/epidemiology ; Rare Diseases/genetics ; Electronic Health Records ; Cluster Analysis
Czasopismo naukowe
Tytuł:
Unravelling the mysteries: a reflection on rare neurological diseases.
Autorzy:
Filosto M; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. .; NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy. .
Mancuso M; Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
Federico A; Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Padovani A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Unit of Neurology, ASST Spedali Civili, Brescia, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Mar; Vol. 45 (3), pp. 833-835.
Typ publikacji:
Editorial
MeSH Terms:
Nervous System Diseases*/diagnosis
Nervous System Diseases*/therapy
Humans ; Rare Diseases
Opinia redakcyjna
Tytuł:
Regional differences in the prevalence of generalized pustular psoriasis in Japan.
Autorzy:
Fujita H; Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
Iwasaki R; Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan.
Tsuboi S; Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan.
Murashiuma Y; Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan.
Akiyama M; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2024 Mar; Vol. 51 (3), pp. 380-390. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/epidemiology
Skin Diseases, Vesiculobullous*
Humans ; Retrospective Studies ; Japan/epidemiology ; Prevalence ; Rare Diseases
Czasopismo naukowe
Tytuł:
Administration with curcumin alleviates spinal cord ischemia-reperfusion injury by regulating anti-oxidative stress and microglia activation-mediated neuroinflammation via Nrf2/NF-κB axis.
Autorzy:
Wu F; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China.; Department of Orthopaedics, Fuzhou Second Hospital, Fuzhou, 350007, People's Republic of China.
Lin Y; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China.; Department of Orthopaedics, Fuzhou Second Hospital, Fuzhou, 350007, People's Republic of China.
Xiao L; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China.; Department of Orthopaedics, Fuzhou Second Hospital, Fuzhou, 350007, People's Republic of China.
Chen Q; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China.
Lin F; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China.; Department of Orthopaedics, Fuzhou Second Hospital, Fuzhou, 350007, People's Republic of China.
Li R; Department of Orthopaedics, Third Clinical College, Fujian Medical University, Fuzhou, 350007, People's Republic of China. .; Department of Orthopaedics, Fuzhou Second Hospital, Fuzhou, 350007, People's Republic of China. .
Pokaż więcej
Źródło:
In vitro cellular & developmental biology. Animal [In Vitro Cell Dev Biol Anim] 2024 Mar; Vol. 60 (2), pp. 172-182. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
MeSH Terms:
Curcumin*/pharmacology
Curcumin*/therapeutic use
Reperfusion Injury*/drug therapy
Reperfusion Injury*/metabolism
Reperfusion Injury*/pathology
Rodent Diseases*/metabolism
Rodent Diseases*/pathology
Rats ; Animals ; NF-kappa B/metabolism ; NF-E2-Related Factor 2/metabolism ; Neuroinflammatory Diseases ; Microglia/pathology ; Oxidative Stress ; Spinal Cord/metabolism ; Spinal Cord/pathology ; Oxygen/metabolism ; Glucose/metabolism
Czasopismo naukowe
Tytuł:
Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.
Autorzy:
Adhikari A; Department of Chemistry, Graphic Era Hill University, Clement Town, Dehradun, Uttarakhand, India. Electronic address: .
Chauhan K; Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, Km 107 carretera, Tijuana-Ensenada, Baja California 22860, Mexico.
Adhikari M; Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Tiwari AK; Department of Chemistry, Babasaheb, Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India.
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Feb 15; Vol. 100, pp. 117628. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Neurodegenerative Diseases*/diagnostic imaging
Neurodegenerative Diseases*/drug therapy
Neurodegenerative Diseases*/metabolism
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor*/antagonists & inhibitors
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor*/metabolism
Aged ; Humans ; Amyloid beta-Peptides/metabolism ; Colony-Stimulating Factors/metabolism ; Microglia/metabolism ; Neuroinflammatory Diseases ; Positron-Emission Tomography/methods ; Receptor Protein-Tyrosine Kinases/metabolism
Czasopismo naukowe
Tytuł:
Omega fatty acid ratios and neurodegeneration in a healthy environment.
Autorzy:
Dere Yelken H; Yeditepe University, 26 August Settlement, Atasehir, Istanbul 34755, Turkey. Electronic address: .
Elci MP; University of Health Sciences Gulhane Health Sciences Institute, Gulhane Complex, Etlik, Ankara 06018, Turkey.
Turker PF; Baskent University, Baglica Campus, Eskisehir highway 18.km Etimesgut, Ankara 06790, Turkey.
Demirkaya S; University of Health Sciences, Gulhane Faculty of Medicine, Etlik, Ankara 06018, Turkey.
Pokaż więcej
Źródło:
Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2024 Feb; Vol. 170, pp. 106799. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Fatty Acids, Omega-3*/pharmacology
Fatty Acids, Omega-3*/therapeutic use
Neurodegenerative Diseases*/drug therapy
Humans ; Fatty Acids ; Neuroinflammatory Diseases ; Cytokines
Czasopismo naukowe
Tytuł:
Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studies.
Autorzy:
Cadenhead KS; University of California San Diego (UCSD), 9500 Gilman Dr, La Jolla, CA 92093-0810, United States of America. Electronic address: .
Mirzakhanian H; University of California San Diego (UCSD), 9500 Gilman Dr, La Jolla, CA 92093-0810, United States of America. Electronic address: .
Achim C; University of California San Diego (UCSD), 9500 Gilman Dr, La Jolla, CA 92093-0810, United States of America. Electronic address: .
Reyes-Madrigal F; Instituto Nacional de Neurología y Neurocirugía (INNN), Insurgentes Sur 3877, Tlalpan, 14269 Mexico City, Mexico. Electronic address: .
de la Fuente-Sandoval C; Instituto Nacional de Neurología y Neurocirugía (INNN), Insurgentes Sur 3877, Tlalpan, 14269 Mexico City, Mexico. Electronic address: .
Pokaż więcej
Źródło:
Schizophrenia research [Schizophr Res] 2024 Feb; Vol. 264, pp. 39-48. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Antipsychotic Agents*/therapeutic use
Psychotic Disorders*
Neurodegenerative Diseases*/chemically induced
Neurodegenerative Diseases*/drug therapy
Humans ; Neuroinflammatory Diseases ; Pilot Projects ; Interleukin-10/therapeutic use ; Glutamic Acid ; Biomarkers
Czasopismo naukowe
Tytuł:
Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study.
Autorzy:
Ahmad Azahari AHS; Department of Paediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Hakim Zada F; Department of Paediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Ismail IH; Clinical Immunology Unit, Department of Paediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
Abd Hamid IJ; Primary Immunodeficiency Diseases Group, Department of Clinical Medicine, Institut Perubatan dan Pergigian Termaju, Universiti Sains Malaysia, Bertam, Pulau Pinang, Malaysia.
Lim BWD; Malaysian Patient Organisation for Primary Immunodeficiencies (MyPOPI), Kuala Lumpur, Malaysia.
Ismail NAS; Hospital Tunku Ampuan Besar Tuanku Aishah Rohani, UKM Specialist Children's Hospital, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Ali A; Department of Paediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; Hospital Tunku Ampuan Besar Tuanku Aishah Rohani, UKM Specialist Children's Hospital, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 12; Vol. 14, pp. 1308305. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Immunologic Deficiency Syndromes*/diagnosis
Immunologic Deficiency Syndromes*/epidemiology
Immunologic Deficiency Syndromes*/genetics
Primary Immunodeficiency Diseases*/diagnosis
Primary Immunodeficiency Diseases*/genetics
Child ; Humans ; Malaysia/epidemiology ; Cross-Sectional Studies ; Genetic Testing ; Parents ; Rare Diseases/genetics ; Perception
Czasopismo naukowe
Tytuł:
Taming microglia: the promise of engineered microglia in treating neurological diseases.
Autorzy:
Luo EY; School of Biological Sciences, Faculty of Science, The University of Hong Kong, Pokfulam, Hong Kong.
Sugimura RR; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2024 Jan 11; Vol. 21 (1), pp. 19. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Microglia*/metabolism
Nervous System Diseases*/therapy
Animals ; Neuroinflammatory Diseases ; Brain ; Cell Culture Techniques
Czasopismo naukowe
Tytuł:
Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway.
Autorzy:
Ma D; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Zhang H; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.; ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
Yin L; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.; Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.; ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
Xu H; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.; ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
Wu L; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.; Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.; ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
Shaji R; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Rezai F; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Mulla A; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Kaur S; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Tan S; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.
Kysela B; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
Wang Y; Department of Neurology, Tiantan Hospital Capital Medical University, National Center and National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Chinese Institute for Brain Research, Beijing, China.
Chen Z; Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
Zhao C; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Gu Y; Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.; Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.; ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
Pokaż więcej
Źródło:
Glia [Glia] 2024 Jan; Vol. 72 (1), pp. 133-155. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Induced Pluripotent Stem Cells*/metabolism
Remyelination*/physiology
Demyelinating Diseases*/chemically induced
Demyelinating Diseases*/therapy
Demyelinating Diseases*/metabolism
Humans ; Mice ; Animals ; Brain-Derived Neurotrophic Factor/metabolism ; Endothelial Cells/metabolism ; Neuroinflammatory Diseases ; Myelin Sheath/metabolism ; Central Nervous System/metabolism ; Oligodendroglia/metabolism ; Cell Differentiation/physiology ; Mice, Inbred C57BL
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies